# XS005 Injection Combined With Stupp Regimen for Adjuvant Chemotherapy in Subjects With Primary Glioblastoma(GBM)

> **NCT06147505** · PHASE1,PHASE2 · SUSPENDED · sponsor: **Dushu Lake Hospital Affiliated to Soochow University** · enrollment: 30 (estimated)

## Conditions studied

- Tumor

## Interventions

- **BIOLOGICAL:** XS005 Injection

## Key facts

- **NCT ID:** NCT06147505
- **Lead sponsor:** Dushu Lake Hospital Affiliated to Soochow University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2023-10-29
- **Primary completion:** 2025-11-02
- **Final completion:** 2025-12-29
- **Target enrollment:** 30 (ESTIMATED)
- **Why stopped:** The hospital is under renovation
- **Last updated:** 2024-10-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06147505

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06147505, "XS005 Injection Combined With Stupp Regimen for Adjuvant Chemotherapy in Subjects With Primary Glioblastoma(GBM)". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06147505. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*